ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,208,130, issued on Jan. 28, was assigned to INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (Paris), UNIVERSITE DE LILLE (Lille, France) and CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE LILLE (Lille, France).

"Treatment of women affected with polycystic ovary syndrome" was invented by Paolo Giacobini (Lille, France) and Vincent Prevot (Lille, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the field of therapeutic treatment of polycystic ovary syndrome (PCOS). Polycystic ovary syndrome, PCOS, is the most common female reproductive disorder against which no therapeutic solution is available, beyon...